Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C43H83NO8S
CAS Number:
Molecular Weight:
774.19
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
grade
Molecular Biology
form
liquid (MES buffered saline)
usage
sufficient for 40 transfections (10 cm dishes)
concentration
1 mg/mL
color
clear to hazy colorless to faint yellow
storage temp.
2-8°C
SMILES string
[H]C(C[N+](C)(C)C)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.O=S([O-])(OC)=O
InChI
1S/C42H80NO4.CH4O4S/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-41(44)46-39-40(38-43(3,4)5)47-42(45)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2;1-5-6(2,3)4/h20-23,40H,6-19,24-39H2,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/b22-20-,23-21-;
InChI key
RSMRWWHFJMENJH-LQDDAWAPSA-M
General description
DOTAP or N-(2, 3-Dioleoyloxy-1-propyl) trimethylammonium methyl sulfate is a cationic liposome-forming compound for transfection of DNA, RNA and other negatively charged molecules into eukaryotic cells.
Application
Cationic liposome-forming compound for transfection of DNA, RNA and other negatively charged molecules into eukaryotic cells. Mixing DOTAP with DNA results in spontaneously formed stable complexes that can be directly added to cell culture medium. These complexes fuse with the cell membrane and release DNA into the cytoplasm. The cells are transfected efficiently without cytotoxic effects. Use approximately 5-10 μg DOTAP per μg DNA and approximately 10-20 μg DOTAP per mL cell culture medium. The optimal working concentration and transfection time depends in part on the cell line used, and the type of material (RNA, DNA, protein) loaded.
Suitable for transient and stable transfection of DNA into cultured mammalian cells. Use approximately 5-10 μg DOTAP per μg DNA and approximately 10-20 μg DOTAP per mL cell culture medium. Protocol optimization within these guidelines provides very efficient transfection. The following cells have been successfully transfected using the DOTAP method:
A549
B6
BHK
BNL CL.2
C2
C6
Cardiomyocytes
CHO
COS-1
COS-7
Embryonic Fibroblasts (rat)
Embryonic stem cells (mouse)
Fibroblasts (primary human)
H225
Hepatocytes (primary rat)
HepG2
HEK293
HeLa
Hippocampal neurons (mouse and rat)
HMEC-1
Huh7
Jurkat
Lymphocytes (human peripheral blood)
M17
Macrophage (mouse)
MCF-7
MDA-MB-435
NIH3T3
Sf9
Smooth Muscle (rat aortic)
Spleen (mouse)
Vero
WI-38
A549
B6
BHK
BNL CL.2
C2
C6
Cardiomyocytes
CHO
COS-1
COS-7
Embryonic Fibroblasts (rat)
Embryonic stem cells (mouse)
Fibroblasts (primary human)
H225
Hepatocytes (primary rat)
HepG2
HEK293
HeLa
Hippocampal neurons (mouse and rat)
HMEC-1
Huh7
Jurkat
Lymphocytes (human peripheral blood)
M17
Macrophage (mouse)
MCF-7
MDA-MB-435
NIH3T3
Sf9
Smooth Muscle (rat aortic)
Spleen (mouse)
Vero
WI-38
Biochem/physiol Actions
A stable complex is formed when DOTAP is mixed with DNA in the absence of serum. The complexes are stable and can be directly added to the cell culture medium, where they fuse with the cell membrane, releasing the DNA into the cytoplasm. Note: complex formation is inhibited by serum, but once stable complexes have formed, the presence of serum is without consequence.
Features and Benefits
- Up to 100x more efficient than calcium phosphate and DEAE transfection
- Lower toxicity than calcium phosphate and DEAE based transfection
- Compatible with both serum and serum-free transfection protocols
- Compatible with in-vivo transfection protocols
Storage Class
12 - Non Combustible Liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Lipid-Based Nanocarriers for RNA Delivery.
Xue HY
Current Pharmaceutical Design, 21(22), 3140-3147 (2015)
Murali Muniraju et al.
Journal of virology, 93(16) (2019-05-31)
Kaposi sarcoma-associated herpesvirus (KSHV) is an emerging pathogen and is the causative infectious agent of Kaposi sarcoma and two malignancies of B cell origin. To date, there is no licensed KSHV vaccine. Development of an effective vaccine against KSHV continues
Lea I Mikkola et al.
PLoS genetics, 15(7), e1008197-e1008197 (2019-07-20)
Canine hip dysplasia is a common, non-congenital, complex and hereditary disorder. It can inflict severe pain via secondary osteoarthritis and lead to euthanasia. An analogous disorder exists in humans. The genetic background of hip dysplasia in both species has remained